Prometheus Biosciences Inc (RXDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2016 | 12-2015 | 12-2014 | 12-2013 | 12-2012 | |
| Sales | 0 | 0 | 150 | 0 | 0 |
| Gross Profit | N/A | N/A | 150 | N/A | N/A |
| Operating Expenses | 100,684 | 90,580 | 40,011 | 13,904 | 1,256 |
| Operating Income | -100,684 | -90,580 | -39,861 | -13,904 | -1,256 |
| Interest Expense | 3,214 | 2,593 | 1,362 | 205 | 23 |
| Other Income | 259 | 715 | 1,233 | -105 | 0 |
| Pre-tax Income | -103,639 | -92,458 | -39,990 | -14,214 | -1,279 |
| Income Tax | N/A | N/A | N/A | N/A | 1 |
| Net Income Continuous | -103,639 | -92,458 | -39,990 | -14,214 | -1,280 |
| Net Income | $-103,639 | $-92,458 | $-39,990 | $-14,214 | $-1,280 |
| EPS Basic Total Ops | -2.69 | -3.44 | -2.18 | -3.83 | -2.00 |
| EPS Basic Continuous Ops | -2.69 | -3.44 | -2.18 | -3.83 | -2.00 |
| EPS Diluted Total Ops | -2.69 | -3.44 | -2.18 | -3.83 | -2.00 |
| EPS Diluted Continuous Ops | -2.69 | -3.44 | -2.18 | -3.83 | -2.00 |
| EPS Diluted Before Non-Recurring Items | -2.69 | -3.44 | -2.18 | -3.83 | N/A |
| EBITDA(a) | $-96,613 | $-88,005 | $-38,965 | $-13,639 | $-1,238 |